<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="a majority of circulating viruses during 2008 became resistant to" exact="oseltamivir" post="prior to the 2009 pandemic.4, 5, 6, 7 Circulation"/>
 <result pre="viral polymerase inhibitor (baloxavir marboxil [Xofluza] approved in 2018).2,3,36 However," exact="amantadine" post="and its derivatives are no longer used because 100%"/>
 <result pre="old (Jackson Laboratories, Bar Harbor, ME, USA), were anesthetized with" exact="isoflurane" post="and administered (5 mice/group) 25 μg of 5′-PPP-NS1shRNA, capped-NS1shRNA,"/>
 <result pre="States—2017–2018 influenza seasonhttps://www.cdc.gov/flu/about/burden/2017-2018.htm2018 2HaydenF.G.AtmarR.L.SchillingM.JohnsonC.PoretzD.PaarD.HusonL.WardP.MillsR.G.Use of the selective oral neuraminidase inhibitor" exact="oseltamivir" post="to prevent influenzaN. Engl. J. Med.34119991336134310536125 3HeoY.A.Baloxavir: First Global"/>
 <result pre="and EFTA countries: an updateEuro Surveill.132008803218445425 5LackenbyA.HungnesO.DudmanS.G.MeijerA.PagetW.J.HayA.J.ZambonM.C.Emergence of resistance to" exact="oseltamivir" post="among influenza A(H1N1) viruses in EuropeEuro Surveill.132008802618445375 6HaugeS.H.DudmanS.BorgenK.LackenbyA.HungnesO.Oseltamivir-resistant influenza"/>
 <result pre="global seasonal influenza-associated respiratory mortality: a modelling studyLancet39120181285130029248255 36WendelH.A.SnyderM.T.PellS.Trial of" exact="amantadine" post="in epidemic influenzaClin. Pharmacol. Ther.7196638435325584 37collab: Centers for Disease"/>
</results>
